From the Pulmonary Disease Program, Vascular Biology Center, Georgia Regents University, Augusta, Georgia 30912.
J Biol Chem. 2014 Mar 14;289(11):7948-61. doi: 10.1074/jbc.M113.534313. Epub 2014 Jan 27.
The cGMP-dependent protein kinase G-1α (PKG-1α) is a downstream mediator of nitric oxide and natriuretic peptide signaling. Alterations in this pathway play a key role in the pathogenesis and progression of vascular diseases associated with increased vascular tone and thickness, such as pulmonary hypertension. Previous studies have shown that tyrosine nitration attenuates PKG-1α activity. However, little is known about the mechanisms involved in this event. Utilizing mass spectrometry, we found that PKG-1α is susceptible to nitration at tyrosine 247 and 425. Tyrosine to phenylalanine mutants, Y247F- and Y425F-PKG-1α, were both less susceptible to nitration than WT PKG-1α, but only Y247F-PKG-1α exhibited preserved activity, suggesting that the nitration of Tyr(247) is critical in attenuating PKG-1α activity. The overexpression of WT- or Y247F-PKG-1α decreased the proliferation of pulmonary artery smooth muscle cells (SMC), increased the expression of SMC contractile markers, and decreased the expression of proliferative markers. Nitrosative stress induced a switch from a contractile to a synthetic phenotype in cells expressing WT- but not Y247F-PKG-1α. An antibody generated against 3-NT-Y247 identified increased levels of nitrated PKG-1α in humans with pulmonary hypertension. Finally, to gain a more mechanistic understanding of how nitration attenuates PKG activity, we developed a homology model of PKG-1α. This model predicted that the nitration of Tyr(247) would decrease the affinity of PKG-1α for cGMP, which we confirmed using a [(3)H]cGMP binding assay. Our study shows that the nitration of Tyr(247) and the attenuation of cGMP binding is an important mechanism regulating in PKG-1α activity and SMC proliferation/differentiation.
环磷酸鸟苷(cGMP)依赖性蛋白激酶 G-1α(PKG-1α)是一氧化氮和利钠肽信号转导的下游介质。该途径的改变在与血管张力和厚度增加相关的血管疾病的发病机制和进展中起着关键作用,例如肺动脉高压。先前的研究表明,酪氨酸硝化会减弱 PKG-1α 的活性。然而,对于这一事件涉及的机制知之甚少。利用质谱分析,我们发现 PKG-1α易受酪氨酸 247 和 425 的硝化作用。酪氨酸到苯丙氨酸的突变体 Y247F-和 Y425F-PKG-1α都比 WT PKG-1α更不易硝化,但只有 Y247F-PKG-1α保留了活性,表明 Tyr(247)的硝化在减弱 PKG-1α的活性中起关键作用。WT-或 Y247F-PKG-1α的过表达降低了肺动脉平滑肌细胞(SMC)的增殖,增加了 SMC 收缩标记物的表达,并降低了增殖标记物的表达。在表达 WT-PKG-1α的细胞中,硝化应激诱导了从收缩表型到合成表型的转变,但在表达 Y247F-PKG-1α的细胞中则没有。针对 3-NT-Y247 的抗体鉴定出肺动脉高压患者中硝化 PKG-1α 的水平升高。最后,为了更深入地了解硝化如何减弱 PKG 活性,我们开发了 PKG-1α 的同源模型。该模型预测 Tyr(247)的硝化会降低 PKG-1α 与 cGMP 的亲和力,我们使用 [(3)H]cGMP 结合测定法对此进行了验证。我们的研究表明,Tyr(247)的硝化和 cGMP 结合的减弱是调节 PKG-1α 活性和 SMC 增殖/分化的重要机制。